title: [Cost analysis of18F-FDG PET-CT from the perspective of the Brazilian Unified National Health System as healthcare provider: a study in a public healthcare center in Rio de Janeiro, Brazil].
abstract: Positron emission tomography (PET) has been introduced recently in Brazil and requires costs analysis to support economic evaluation studies on its use. The current study analyzed the use of 18 F-FDG PET-CT and estimated its costs from the perspective of a public healthcare provider. The micro-costing technique was used, identifying, quantifying, and valuing all the inputs used to perform the procedure. Cost estimates considered 85 tests performed at the Brazilian National Cancer Institute from March to June 2012. Reference cases were defined as adult cancer patients, output of five tests per day, and one dose of 18 F-FDG per patient. Unit cost for the procedure was BRL 3,150.30 based on career wages under the Ministry of Science and Technology and BRL 2,927.19 based on Ministry of Health career wages. The factor with the heaviest cost impact was daily output of tests. Other factors that could impact the test's cost in public healthcare institutions were also examined.
authors.affiliation: Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil, Instituto de Medicina Social , Universidade do Estado do Rio de Janeiro , Rio de Janeiro , Brasil .
authors.forename: Rosângela
authors.initials: R
authors.lastname: Caetano
authors.affiliation: Instituto Nacional de Câncer, Rio de Janeiro, Brasil, Instituto Nacional de Câncer , Rio de Janeiro , Brasil .
authors.forename: Luciene Fontes
authors.initials: LF
authors.lastname: Schluckebier
authors.affiliation: Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil, Instituto de Medicina Social , Universidade do Estado do Rio de Janeiro , Rio de Janeiro , Brasil .
authors.forename: Cláudia Regina Garcia
authors.initials: CR
authors.lastname: Bastos
authors.affiliation: Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil, Instituto de Medicina Social , Universidade do Estado do Rio de Janeiro , Rio de Janeiro , Brasil .
authors.forename: Rondineli Mendes da
authors.initials: RM
authors.lastname: Silva
authors.affiliation: Instituto Nacional de Câncer, Rio de Janeiro, Brasil, Instituto Nacional de Câncer , Rio de Janeiro , Brasil .
authors.forename: Michel Pontes
authors.initials: MP
authors.lastname: Carneiro
authors.affiliation: Instituto Nacional de Câncer, Rio de Janeiro, Brasil, Instituto Nacional de Câncer , Rio de Janeiro , Brasil .
authors.forename: Jorge Wagner Esteves da
authors.initials: JW
authors.lastname: Silva
authors.affiliation: Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil, Instituto de Medicina Social , Universidade do Estado do Rio de Janeiro , Rio de Janeiro , Brasil .
authors.forename: Aline Navega
authors.initials: AN
authors.lastname: Biz
mesh_terms: D001938:Brazil; D003362:Cost-Benefit Analysis; D019788:Fluorodeoxyglucose F18; D006801:Humans; D064847:Multimodal Imaging / Q000191:economics* / Q000379:methods; D009313:National Health Programs; D049268:Positron-Emission Tomography / Q000191:economics* / Q000379:methods; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000191:economics*
chemical_list: D019788:Fluorodeoxyglucose F18